A Trial to Determine the Efficacy and Safety of Presendin in IIH
Public ClinicalTrials.gov record NCT05347147. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomised, Placebo-controlled, Double-blind, Multi-centre, Clinical Trial to Determine the Efficacy and Safety of Presendin in Idiopathic Intracranial Hypertension
Study identification
- NCT ID
- NCT05347147
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Invex Therapeutics Ltd.
- Industry
- Enrollment
- 14 participants
Conditions and interventions
Conditions
Interventions
- Presendin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2022
- Primary completion
- Sep 17, 2023
- Completion
- Oct 19, 2023
- Last update posted
- Apr 23, 2024
2022 – 2023
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCHealth Sue Anschutz-Rodgers Eye Center - Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| University of Miami Leonard M. Miller School of Medicine (UMMSM) - Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| University of Minnesota Health | Minneapolis | Minnesota | 55455 | — |
| New York Eye and Ear Infirmary of Mount Sinai | New York | New York | 10075 | — |
| Vanderbilt Eye Institute | Nashville | Tennessee | 37232 | — |
| The University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Neuro-Eye Clinical Trials, Inc | Houston | Texas | 77074 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05347147, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05347147 live on ClinicalTrials.gov.